The AcornUI series is a suite of non-invasive genomic urine tests designed to help rule out bladder cancer, ureteral cancer and renal pelvic cancer and to monitor the recurrence of bladder cancer.
AcornUPro-SEEK is a non-invasive urine genomic test for ruling out prostate cancer.